Court Opinion in Novartis/United Therapeutics Challenges to 340B Contract Pharmacies Obligations (November 5, 2021)

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA

NOVARTIS PHARMACEUTICALS
CORPORATION,

                            Plaintiff,
v.                                                                                 No. 21-cv-1479 (DLF)

DIANA ESPINOSA,
Acting Administrator, Health Resources and
Services Administration, et al.,

                           Defendants.

__________________________________

UNITED THERAPEUTICS
CORPORATION,

                          Plaintiff,
v.                                                                                No. 21-cv-1686 (DLF)

DIANA ESPINOSA,
Acting Administrator, Health Resources and
Services Administration, et al.,

Defendants.

 

MEMORANDUM OPINION

This case concerns conditions that plaintiffs Novartis Pharmaceuticals Corporation and United Therapeutics Corporation have imposed on discounted drug purchases by certain safety­net health care providers. The plaintiffs brought this suit to prevent threatened enforcement actions by the Health Resources and Services Administration (HRSA). Before the Court are the plaintiffs' Motions for Summary Judgment, Dkt. 19 (Novartis); Dkt. 14 (United Therapeutics), and the defendants' Motions for Summary Judgment, Dkt. 13 (Novartis), Dkt. 16 (United Therapeutics). 1 For the reasons that follow, the Court will grant in part and deny in part the plaintiffs' motions for summary judgment and deny the defendants' motions.

View the entire Court Opinion below.